Skip to main content
. 2020 Jul 28;26(28):4094–4107. doi: 10.3748/wjg.v26.i28.4094

Figure 1.

Figure 1

Effect of thioacetamide and celecoxib on liver fibrosis. A: Macroscopic analysis of liver tissue. Celecoxib improved pathological changes in the liver, as shown by hematoxylin-eosin and Sirius red (SR) staining (original magnification: × 100; scale bar = 400 μm); B: Ishak’s score based on histology and SR staining as well as alanine aminotransferase, aspartate aminotransferase, and hydroxyproline levels. The data are expressed as the mean ± SD (n = 15, aP < 0.05 vs TAA + celecoxib group; bP < 0.01 vs control group). TAA: Thioacetamide; ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; HE: Hematoxylin-eosin staining.

HHS Vulnerability Disclosure